Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Symptom C0019204|hepatocellular carcinoma
Sentences 117
PubMedID- 24081938 Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted.
PubMedID- 21129375 Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 26446006 Background and objectives: we studied the effect of achieving sustained virological response (svr) on the risk of developing hepatocellular carcinoma (hcc) in patients with hepatitis c receiving anti-hepatitis c virus treatment.
PubMedID- 25544880 Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri.
PubMedID- 21563203 Inactivation of klf6 is common in hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection, thereby abrogating its normal antiproliferative activity in liver cells.
PubMedID- 23602201 High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 26508201 Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis c after the eradication of hepatitis c virus: a multicenter study from japan.
PubMedID- 25650331 Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.
PubMedID- 25654412 Results: there were 109 patients with hepatocellular carcinoma associated with hepatitis c virus that underwent living-donor liver transplant from july 2002 to june 2012.
PubMedID- 24752298 Chronic hepatitis c (chc) can lead to cirrhosis and hepatocellular carcinoma (lauer and walker, 2001).
PubMedID- 22588449 Skull metastasis from hepatocellular carcinoma with hepatitis c.
PubMedID- 21056500 The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.
PubMedID- 26017875 Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus.
PubMedID- 21619694 Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma , suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor.
PubMedID- 22957141 End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2.
PubMedID- 20981260 A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct).
PubMedID- 24703510 Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection.
PubMedID- 21253791 Several noncurative treatments also appear to reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 24463696 Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 22919246 A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis c virus patients with hepatocellular carcinoma.
PubMedID- 21610221 Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis.
PubMedID- 23395693 Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis c: further evidence in decompensation cirrhosis.
PubMedID- 26305067 A variant in pnpla3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 22875473 Inhibition of hepatocellular carcinoma by pegifnalpha-2a in patients with chronic hepatitis c: a nationwide multicenter cooperative study.
PubMedID- 26394142 End-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) infection constitute one of the main indications for liver transplantation (lt) worldwide 1.
PubMedID- 24677195 hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach.
PubMedID- 21278701 The incidence of hepatocellular carcinoma associated with hepatitis c infection decreased in kyushu area.
PubMedID- 21931376 Frequency of elevated hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c.
PubMedID- 21157144 A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis c virus received a liver transplantation.
PubMedID- 20458764 Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c.
PubMedID- 20616578 Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus.
PubMedID- 23657093 Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death 2.
PubMedID- 24037287 In fact, diverse studies have already correlated viral exposure to epigenetic alterations and human cancer such as hepatitis b virus and hepatitis c virus with hepatocellular carcinoma1626.
PubMedID- 26012225 This study elucidated the role of insulin resistance assessed by the homeostasis model (homa-ir) in development of hepatocellular carcinoma associated with chronic hepatitis c infection.
PubMedID- 21718500 Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus .
PubMedID- 21461077 Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated.
PubMedID- 24843320 Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection.
PubMedID- 22410057 The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1).
PubMedID- 22419005 Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 20883676 Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection.
PubMedID- 24179611 Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis.
PubMedID- 22105231 Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis c virus infection receiving interferon therapy: a single center study.
PubMedID- 23701091 Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis.
PubMedID- 23982634 Effect of occult hepatitis b virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 24462733 A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis.
PubMedID- 23122451 Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c.
PubMedID- 22555181 A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis c or b: a novel approach by using meta-regression.
PubMedID- 22207106 Randomized controlled trials also confirm that glycyrrhizin and its derivatives can improve the hepatocellular injury in chronic hepatitis b or c patients, and reduce the risk for hepatocellular carcinoma in patients with hepatitis c virus-induced cirrhosis .
PubMedID- 22615799 Similarly, hepatitis c infections are strongly associated with hepatocellular carcinomas, and schistosomiasis is a major cause of bladder cancer .
PubMedID- 25331666 Increased risk of hepatocellular carcinoma in patients with chronic hepatitis c.

Page: 1 2 3